Clinical trial

Honey Dressing - A Preventive Procedure for Post-Surgical Site Infection

Name
HITEC-IMS-01-2022
Description
The goal of this clinical trial is to compare the wound healing in the participants who underwent the clean surgical procedure, by applying honey dressing and common Iodine solution dressing, participants will have no other co-morbidities like Diabetes, Anemia, etc. which can make the results biased. The main questions it aims to answer are: * Do the iodine solutions are enough to counter the infections caused by resistant strains of bacteria? * What is the efficacy and efficiency of honey dressing in wound care? Participants will be tasked to * Ensure strict follow-up in the hospital dressing room * Half of the participants will apply common iodine solution dressing and the other half will be applied honey dressing. Researchers will compare Iodine dressing (Control group) with Honey dressing (Experimental group) to see if Honey dressing is better in the prevention of post-surgery wound infection and if it is cost-efficient and its efficacy.
Trial arms
Trial start
2022-12-02
Estimated PCD
2023-03-03
Trial end
2023-03-03
Status
Completed
Phase
Early phase I
Treatment
Honey Dressing
Honey Dressing will be applied from the 1st Post-Op day till the fully healed wound, which is described as no dehiscence, no exudate, no warmth, and sutures removed.
Arms:
Honey
Iodine Dressing
Iodine Dressing will be applied from the 1st Post-Op day till the fully healed wound, which is described as no dehiscence, no exudate, no warmth, and sutures removed.
Arms:
Aseptic Iodine
Other names:
Iodine solution dressing
Size
80
Primary endpoint
Signs of Wound Infection
3rd day, 7th day, 15th day.
Eligibility criteria
Inclusion Criteria: Patients with sterile/clean post-surgical wounds are admitted in general surgery, neurosurgery, orthopedic, and gynecology wards and require follow-up dressings. Exclusion Criteria: 1. Patients with: * Anemia * BMI\>30 * Local Infection in wound area. * Venous leg ulcers * Diabetes * Immunocompromised (Oncological patients) 2. Patient under negative pressure therapy
Protocol
{'studyType': 'INTERVENTIONAL', 'phases': ['PHASE2', 'PHASE3'], 'designInfo': {'allocation': 'RANDOMIZED', 'interventionModel': 'PARALLEL', 'primaryPurpose': 'PREVENTION', 'maskingInfo': {'masking': 'TRIPLE', 'whoMasked': ['PARTICIPANT', 'CARE_PROVIDER', 'OUTCOMES_ASSESSOR']}}, 'enrollmentInfo': {'count': 80, 'type': 'ACTUAL'}}
Updated at
2024-01-25

1 organization

2 products

4 indications

Indication
Wound Infection
Indication
Bleeding
Indication
Surgical Wound